No Routine Cancer Screening Option? New MCED Tests May Help No Routine Cancer Screening Option? New MCED Tests May Help
Early data suggest that several new multicancer early detection tests can identify a range of cancers that lack routine screening options.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Further Support for CRC Screening to Start at Age 45 Further Support for CRC Screening to Start at Age 45
Adenoma detection rates were shown to be comparable between 45-49-year-olds and 50-54-year-olds.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Gastroenterology Clinical Summary Source Type: news
Ovarian Cancer: Another Promising Target for Liquid Biopsy Ovarian Cancer: Another Promising Target for Liquid Biopsy
A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Findings: More Cancer Diagnoses, Fewer Cancer Deaths New Findings: More Cancer Diagnoses, Fewer Cancer Deaths
Dr Maurie Markman discusses the American Cancer Society Annual Report.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
O.J. Simpson Dies After Cancer Battle
(MedPage Today) -- O.J. Simpson, the decorated football superstar and Hollywood actor who was acquitted of charges he killed his former wife and her friend but later found liable in a separate civil trial, has died after a battle with prostate... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 11, 2024 Category: Hematology Source Type: news
More Adults Are Participating in Cancer Clinical Trials More Adults Are Participating in Cancer Clinical Trials
New estimates suggest that more adults with cancer are participating in cancer trial research, especially at National Cancer Institute –designated centers, but overall enrollment rates remain low.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
What to Know About the Next-Gen FIT for CRC Screening What to Know About the Next-Gen FIT for CRC Screening
Several new multitarget stool-based screening tests on the horizon may improve early colorectal cancer detection, according to findings from recent analyses.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2024 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
S3 Episode 3: Advances in Treating Women with Lung Cancer S3 Episode 3: Advances in Treating Women with Lung Cancer
Drs Jacob Sands and Narjust Florez discuss the nuances of treating women with lung cancer, including screening, treatment, and sexual and reproductive health.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2024 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
ImPrint Identifies Treatment for Patients With Breast Cancer ImPrint Identifies Treatment for Patients With Breast Cancer
Data from the ongoing phase 2 trial show that clinicians can use ImPrint, an immune-related biomarker, to identify breast cancer patients who are likely to respond to neoadjuvant immunotherapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 11, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer
(MedPage Today) -- SAN DIEGO -- Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) who received atezolizumab (Tecentriq) after undergoing multimodal definitive therapy failed to achieve a statistically meaningful... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 10, 2024 Category: Hematology Source Type: news
Liquid Biopsy Shows Promise in Detecting Pancreatic Cancer Liquid Biopsy Shows Promise in Detecting Pancreatic Cancer
A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - April 10, 2024 Category: Pathology Tags: Hematology-Oncology Source Type: news
Combo Therapy Prolongs Survival in Gastric Cancer Patients Combo Therapy Prolongs Survival in Gastric Cancer Patients
The overall survival advantage held regardless of PD-L1 status in patients receiving the first-line combination of cadonilimab and standard chemotherapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Intermediate Endpoints Predict Breast Cancer Survival Intermediate Endpoints Predict Breast Cancer Survival
Data suggest that intermediate clinical endpoints can serve as surrogate endpoints for overall survival in patients with early-stage breast cancer receiving adjuvant therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors
(MedPage Today) -- SAN DIEGO -- Levels of aging-associated biomarkers increased significantly in people born in 1965 or later, coinciding with subsequent increases in early-onset cancers, a large prospective-cohort study showed.
As compared... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 9, 2024 Category: Hematology Source Type: news
Novel PARP1 Inhibitor Shows Promise in Breast Cancer
(MedPage Today) -- SAN DIEGO -- Saruparib, an investigational selective PARP1 inhibitor, showed promising activity in patients with certain homologous recombination repair (HRR)-deficient breast cancers, while limiting toxicity, according to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 9, 2024 Category: Hematology Source Type: news
